Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Sep 11, 2024 · 10-Q · 42 days after period end · 0001214659-24-016346
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$974.41K | -$3.53M | -$3.04M | -$2.32M |
| EPS Diluted | -$1.25 | -$5.38 | -$0.03 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Jul 31, 2024 · filed Sep 11, 2024 · 42 d after period end
